News

The antisense drug ISIS-PTP1BRx is intended to increase the body’s sensitivity to the natural hormone insulin, helping in better glucose control for patients suffering from type 2 diabetes.

The trial was designed to investigate the tolerability, safety, efficacy and pharmacokinetics of INO-8875 delivered as an eye-drop formulation in patients with primary open-angle glaucoma or ocular hypertension.

Boca’s Hydrocodone Bitartrate and Acetaminophen Oral Solution, 7.5mg / 325mg per 5ml is the generic version of FSC Laboratories’ Hycet Oral Solution. Boca CEO Robert Edwards said they

The company expects to get the European Commission’s marketing authorization approval for the intensive care sedative dexdor in few months. When approved, the drug can be marketed by

X-22 comprises a kit of very low nicotine (VLN) cigarettes made from 22nd Century’s proprietary tobacco. The X-22 therapy protocol allows patients to smoke X-22 cigarettes without restriction

Initially, the partnership will be focused on branded pharmaceutical products for cardiovascular and metabolic diseases. Under the deal, both the parties will offer combined portfolio of drugs for

The tie up allows HUYA to attend project promotion events and participate in the annual Health and Development Zhongshan Forums at the park, or conduct HUYA’s partners to

The product is comparable to GlaxoSmithKline’s stop smoking aid Nicorette Cinnamon Surge coated gum. Perrigo chairman and CEO Joseph Papa said the expanded range of smoking cessation products

Remicade is indicated for the treatment of pediatric patients with moderately to severely active UC, who have had an inadequate response to conventional therapy earlier. The committee’s decision